National Comprehensive Cancer Network



About NCCN

Non-Hodgkin`s Lymphomas Panel - Disclosures as of 7/18/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Attendance

Jeremy S. Abramson, MD

None

Seattle Genetics, Inc.

None

None

None

Ranjana H. Advani, MD

None

Eisai Inc.;
Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
Seattle Genetics

None

None

None

C. Babis Andreadis, MD, MSCE

GlaxoSmithKline

None

None

None

Genentech, Inc.

Nancy Bartlett, MD

AstraZeneca Pharmaceuticals LP;
Celgene Corporation;
Genentech, Inc.;
Jannsen Pharmaceutica Products, LP;
MedImmune Inc.;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Seattle Genetics;
Pfizer Inc.;
Pharmacyclics

None

None

None

None

Naresh Bellam, MD, MPH

None

Celgene Corporation

None

None

None

John C. Byrd, MD

None

None

None

None

None

Myron S. Czuczman, MD

Celgene Corporation;
Onyx Pharmaceuticals, Inc.;
Gilead

None

None

None

None

Mary Dwyer, MS

None

None

None

None

None

Luis E. Fayad, MD

Centocor, Inc.;
Eisai Inc.;
Eli Lilly and Company;
Genentech, Inc.;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Roche Laboratories, Inc.;
Roche Laboratories, Inc.;
sanofi-aventis U.S.;
Wyeth Pharmaceuticals

None

None

None

None

Richard I. Fisher, MD

None

Boehringer Ingelheim GmbH;
Bio Linx;
Hoffman LaRoche;
Micromet;
Pfizer Inc.

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Martha J. Glenn, MD

None

None

None

None

None

Leo I. Gordon, MD

None

CureTech Ltd.

None

CureTech Ltd.

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Nancy Lee Harris, MD

Pharmacyclics

None

None

None

None

Richard T. Hoppe, MD

None

Takeda Pharmaceuticals North America, Inc.

None

None

None

Steven M. Horwitz, MD

None

Amgen Inc.;
Bristol-Myers Squibb Company;
Celgene Corporation;
Genzyme Corporation;
Jannsen Pharmaceutica Products, LP;
Millennium Pharmaceuticals, Inc.;
Kiowa-Kirin

None

None

None

Christopher R. Kelsey, MD

None

None

None

None

None

Youn H. Kim, MD

None

Celgene Corporation;
Eisai Inc.;
Millennium Pharmaceuticals, Inc.;
Medicis

None

None

None

Susan Krivacic, MPAff

None

None

None

None

None

Ann S. LaCasce, MD

None

GlaxoSmithKline

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Auayporn Nademanee, MD

None

None

None

None

None

Elise A. Olsen, MD

None

Merck & Co., Inc.

None

None

None

Pierluigi Porcu, MD

None

None

None

None

None

Oliver Press, MD, PhD

Genentech, Inc.;
Roche Laboratories, Inc.

BIND Biosciences

None

Emergent Biosolutions

None

Rachel Rabinovitch, MD

None

None

None

None

None

Nishitha Reddy, MD

None

Celgene Corporation;
Celgene Corporation;
Seattle Genetics

None

None

None

Erin Reid, MD

None

None

None

None

None

Lubomir Sokol, MD, PhD

None

Alexion Pharmaceuticals, Inc.;
Celgene Corporation;
Allos

None

None

None

Lode J. Swinnen, MB, ChB

Abbott Laboratories

None

None

None

None

Christina Tsien, MD

None

None

None

None

None

Julie M. Vose, MD, MBA

None

None

None

None

None

William G. Wierda, MD, PhD

Abbott Laboratories;
GlaxoSmithKline

Celgene Corporation;
Genentech, Inc.;
Roche Laboratories, Inc.

None

None

None

Joachim Yahalom, MD

None

None

None

None

None

Nadeem Zafar, MD

None

None

None

None

None

Andrew D. Zelenetz, MD, PhD

None

Celgene Corporation;
Genentech, Inc.;
GlaxoSmithKline;
Onyx Pharmaceuticals, Inc.;
Bullet Bio Technology;
Cancer Genetics;
Dr. Reddy`s Laboratories;
Emergent Biosolutions;
Foundation Medicine;
Gilead;
Hospira;
Roche Laboratories, Inc.;
sanofi-aventis U.S.

None

None

None